Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Delirium19.13.02.0010.237815%
Delusion19.10.01.001--
Depressed level of consciousness17.02.04.0020.034973%
Depressed mood19.15.02.0010.020984%Not Available
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diabetes mellitus14.06.01.001; 05.06.01.0010.230821%Not Available
Diarrhoea07.02.01.001--
Diplegia17.01.04.015--Not Available
Diplopia17.17.01.005; 06.02.06.0020.027978%Not Available
Discomfort08.01.08.0030.048962%Not Available
Disorientation19.13.01.002; 17.02.05.015--Not Available
Disseminated intravascular coagulation24.01.01.010; 01.01.02.0020.010948%
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Drug dependence19.07.02.009--Not Available
Drug hypersensitivity10.01.01.0010.293772%Not Available
Dysarthria19.19.03.001; 17.02.08.0010.020984%
Dysgeusia17.02.07.003; 07.14.03.0010.048962%
Dyskinesia17.01.02.0060.020984%
Dyspepsia07.01.02.001--
Dysphagia07.01.06.0030.062951%
Dysphonia17.02.08.004; 22.02.05.005; 19.19.03.0020.034973%
Dysphoria19.04.02.0040.041967%Not Available
Dyspnoea02.01.03.002; 22.02.01.0040.524593%
Dysuria20.02.02.0020.020984%
Ecchymosis24.07.06.002; 23.06.01.001; 01.01.03.001--Not Available
Encephalitis viral17.06.06.002; 11.05.04.0100.013989%Not Available
Encephalopathy17.13.02.0010.041967%
Eosinophilia01.02.04.0010.041967%
Epilepsy17.12.03.0020.076940%Not Available
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 17 Pages